Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cagrisema Leads The Charge For 2025

Jun 19 2024

• By Elizabeth Cairns

Money in sack on wooden table

Related Content

Moderna Shows Ambition With Flu Success And Cancer Therapy Expansion

Sep 14 2023

Cytokinetics’ Aficamten Data Could Be Best In Class, Cardiologists Say

May 13 2024

Merck Hits Brakes On Anti-PD-1/TIGIT Study In Adjuvant Melanoma

May 13 2024

The Biggest Drug Launches Expected In 2024

Jan 30 2024

Related Companies

Novo Nordisk A/S

Eli Lilly and Company

Cytokinetics, Inc.

Bristol Myers Squibb Company

Moderna, Inc.

GSK plc

Merck & Co., Inc.

Additional Topics

Launches Companies Commercial Sales & Earnings Evaluate Data Vaccines Research & Development Cancer Cardiovascular Immune Disorders Infectious Diseases Metabolic Disorders Oncology Respiratory Renal BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window